Promising therapeutic effect of thapsigargin nanoparticles on chronic kidney disease through the activation of Nrf2 and FoxO1. [electronic resource]
Producer: 20201001Description: 9875-9892 p. digitalISSN:- 1945-4589
- Adenine
- Animals
- Autophagy -- drug effects
- Cell Line
- Drug Evaluation, Preclinical
- Endoplasmic Reticulum Stress -- drug effects
- Forkhead Box Protein O1 -- metabolism
- Humans
- Male
- Mice
- Mice, Inbred C57BL
- NF-E2-Related Factor 2 -- metabolism
- Nanoparticles -- chemistry
- Renal Insufficiency, Chronic -- drug therapy
- Thapsigargin -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.